Monitoring Method and Apparatus for Fractional Photo-Therapy Treatment

• US 20070049996A1
• Filed: 08/29/2006
• Published: 03/01/2007
• Est. Priority Date: 08/29/2005
• Status: Abandoned Application

• Current Assignee: Reliant Technologies, Inc. (Bausch Health Cos., Inc.)
• Original Assignee: Reliant Technologies, Inc. (Bausch Health Cos., Inc.)
• Inventors: Black, John
• Application Number:
  US11/468,264
• Publication Number:
  US 20070049996A1
• Time in Patent Office: Days
• US Class Current: 607/89
• CPC Class Codes: A61B 18/20 using laser
• CPC Class Codes: A61B 18/203 applying laser energy to the outside of the body
• CPC Class Codes: A61B 2017/00057 Light
• CPC Class Codes: A61B 2018/00452 Skin
• CPC Class Codes: A61B 2018/00904 Automatic detection of target tissue

Abstract

A monitoring method for tissue treatment by fractional photo-therapy includes recording a fluorescence image of an area of tissue being treated and electronically processing the image to provide a measure of either progress of the treatment or an applied treatment radiation dose. Fluorescence is generated by irradiating the tissue with ultraviolet (UV) or blue radiation to stimulate fluorescence of one or more chromophores in the tissue. The monitoring method may be applied to control a treatment light source in phototherapy apparatus. In one example of phototherapy apparatus, a handpiece for delivering treatment light to the tissue includes a source of the UV radiation and a CCD camera for recording the fluorescence image.

Claims

1. A method of monitoring fractional photo-therapy treatment, the fractional phototherapy treatment including delivery of treatment radiation in a pattern of treatment zones to an area of tissue, the method comprising the steps of:

irradiating the area of tissue being treated with electro-magnetic radiation thereby stimulating emission of fluorescence radiation from one or more fluorophores in the area of tissue being treated;

recording one or more images of the area of tissue using the fluorescence radiation emitted from at least one of said fluorophores, said images having a spatial distribution of fluorescence depending on structural features of the area of tissue combined with features characteristic of the pattern of treatment-radiation delivery; and

electronically processing said one or more images to identify the fluorescence radiation in said one or more images resulting from the delivery of the treatment radiation.

2. The method of claim 1, wherein said irradiating and recording steps are carried out after delivery of the treatment radiation.

3. The method of claim 1, wherein treatment radiation zones in the pattern of treatment radiation are substantially equally spaced and said electronic processing includes analyzing at least one region of at least one of said one or more images to isolate periodically occurring features thereof resulting from the substantially equally spaced treatment radiation zones in the pattern of the treatment radiation.

4. The method of claim 3, wherein said analyzing includes generating a Fourier transform of said image region.

5. The method of claim 4, wherein said electronic processing includes interpreting a peak value of said Fourier transform as a measure of the progress of the fractional photo-therapy treatment.

6. The method of claim 4, wherein said electronic processing includes interpreting a peak value of said Fourier transform as a measure of the treatment radiation dose delivered to the area of tissue being treated.

7. The method of claim 1, wherein said fluorophores include at least one of tryptophan, porphyrins, NAD-H, flavins, elastin, and collagen and a majority of said fluorescent emission used for recording said images is emitted from said fluorophore.

8. The method of claim 1, wherein first and second images are recorded, said first image being recorded using fluorescence radiation in a first band of wavelengths characteristic of emission from a first of said fluorophores and said second image being recorded using fluorescence radiation in a second band of wavelengths characteristic of emission from a second and different of said fluorophores.

9. The method of claim 8, wherein said first fluorophore is reduced nicotinamide adenine dinucleotide (NAD-H), and said second fluorophore is elastin.

10. The method of claim 8, wherein said electronic processing includes one of adding, subtracting, dividing, and multiplying said first and second images.

11. The method of claim 8, wherein said first and second images are recorded using respectively first and second recording devices.

12. The method of claim 8, wherein said first and second images are recorded sequentially using a single recording device.

13. A method of monitoring fractional photo-therapy treatment, the fractional phototherapy treatment including delivery of treatment radiation in a regular pattern of spaced-apart zones to an area of tissue, the method comprising the steps of:

irradiating the area of tissue with electro-magnetic radiation thereby stimulating emission of fluorescence radiation from reduced nicotinamide adenine dinucleotide (NAD-H) in the area of tissue, the amount of NAD-H in the tissue in and around zones thereof to which treatment radiation is delivered being dependent on the amount of radiation delivered to the zones;

recording a first image of the area of tissue in a wavelength range characteristic of NAD-H fluorescence radiation, said first image having a spatial distribution of fluorescence including background features dependent on structural features of the area of tissue combined with regularly distributed features characteristic of the pattern of treatment-radiation delivery; and

electronically processing said first image to separate said regularly distributed features of said image from said background features and thereby provide a measure of the fluorescence in said image resulting from delivery of the treatment radiation to the area of tissue.

14. The method of claim 13, wherein said separation of said regularly distributed features from said background features includes generating a Fourier transform of a region of said image.

15. The method of claim 14, wherein said electronic processing includes interpreting a peak value of said Fourier transform as a measure of the progress of the fractional photo-therapy treatment.

16. The method of claim 14, wherein said electronic processing includes interpreting a peak value of said Fourier transform as a measure of the treatment radiation dose delivered to the area of tissue.

17. The method of claim 13, wherein said separation of said regularly distributed features from said background features includes the steps of recording a second image in a wavelength range characteristic of the fluorescence spectrum of elastin, the fluorescence of which is not substantially affected by delivery of treatment radiation thereto, such that said second image does not include features representative of said the pattern of treatment-radiation delivery;

and comparing said second image with said first image.

18. Apparatus for photo-thermal treatment of tissue, comprising:

a source of treatment radiation;

an arrangement for delivering treatment radiation from said treatment radiation source to an area of tissue being treated;

a source of fluorescence-stimulating radiation, said fluorescence-stimulating radiation having a range of wavelengths selected to stimulate fluorescence from one or more fluorophores in the area of tissue being treated;

a camera for recording one or more images of the area of tissue being treated at a wavelength of the stimulated fluorescence;

electronic circuitry, cooperative with said treatment-radiation source and said camera; and

wherein said electronic circuitry is arranged to analyze said one or more recorded images and determine from said analysis the progress of the photo-thermal treatment in said area of skin being treated, and arranged to control said treatment-radiation source responsive to said determination.

19. The apparatus of claim 18, wherein said controlling of said treatment-radiation source includes preventing said treatment-radiation source from delivering radiation if said determination is that said area of tissue has already been treated.

20. The apparatus of claim 18, wherein such controlling of said treatment-radiation source includes altering parameters of the treatment radiation delivered by said treatment-radiation source in response to said determination.

21. The apparatus of claim 18, wherein said fluorescence-stimulating-radiation source and said camera are contained in delivery apparatus remote from said treatment-radiation source, wherein an optical arrangement is provided for transporting said treatment-radiation from said treatment-radiation source to said delivery apparatus, and wherein said delivery apparatus is arranged to deliver said treatment and fluorescence-stimulating radiations to tissue to be treated.